New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
16:25 EDTCAPR, CAPR, CAPRCapricor Therapeutics to host business news update conference call
Dr. Linda Marbán, Chief Executive Officer, provides an update on the Company's lead product candidate, CAP-1002 and discusses other Company updates on a conference call to be held on May 15 at 4:30 pm. Webcast Link
News For CAPR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 18, 2015
16:11 EDTCAPRCapricor Therapeutics reports FY14 EPS (53c), one estimate (50c)
As of December 31, 2014, the company had cash, cash equivalents and marketable securities totaling approximately $8M, plus approximately $3M restricted cash from the company's California Institute for Regenerative Medicine loan award, totaling approximately $11M. These amounts represent increases from the approximate $1.7M in cash, cash equivalents and marketable securities and the approximate $1.4M restricted cash from the CIRM loan award, each as of December 31, 2013.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use